Page last updated: 2024-11-05

diphenylacetaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

diphenylacetaldehyde: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13696
CHEMBL ID4460620
SCHEMBL ID193931
MeSH IDM0475479

Synonyms (42)

Synonym
unii-gmf2b8r7dd
gmf2b8r7dd ,
4-07-00-01400 (beilstein handbook reference)
wln: vhyr&r
acetaldehyde, diphenyl-
benzeneacetaldehyde, .alpha.-phenyl-
nsc-21645
diphenylacetaldehyde
diphenylketen
947-91-1
nsc21645
alpha-phenylbenzeneacetaldehyde
ai3-20753
nsc 21645
brn 1424292
2,2-diphenylacetaldehyde
benzeneacetaldehyde, alpha-phenyl-
einecs 213-433-7
inchi=1/c14h12o/c15-11-14(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-11,14
diphenylacetaldehyde, 97%
D2492
AKOS001043900
diphenylethanal;diphenylketen;alpha-phenylbenzeneacetaldehyde;diphenyl-acetaldehyde
A24644
2,2-diphenyl-acetaldehyde
FT-0625248
diphenyl-acetaldehyde
diphenylacetoaldehyde
SCHEMBL193931
2-phenyl-benzeneacetaldehyde
diphenylethanal
J-800292
n-[(4-aminophenyl)carbamothioyl]-4-(2-methyl-2-propanyl)benzamide
J-640468
DTXSID80241575
mfcd00006972
CHEMBL4460620
SY051214
DS-14725
AMY4148
EN300-17215
Z56899117
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1602658Inhibition of mouse GAT-1 assessed as percentage of remaining specific binding of NO711 at 1 uM after 4 hrs by LC-ESI-MS/ms analysis relative to control2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Screening oxime libraries by means of mass spectrometry (MS) binding assays: Identification of new highly potent inhibitors to optimized inhibitors γ-aminobutyric acid transporter 1.
AID1544945Inhibition of NO711 binding to mouse GAT1 expressed in HEK293 cell membranes assessed as residual binding at 1 uM incubated for 4 hrs in presence of NO711 by LC-ESI-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
Application of the concept of oxime library screening by mass spectrometry (MS) binding assays to pyrrolidine-3-carboxylic acid derivatives as potential inhibitors of γ-aminobutyric acid transporter 1 (GAT1).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.88 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]